Post hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock

Journal of Trauma

Volumn 52, Issue 5, 2002, Pages 887-895

  Sloan, Edward P ^a   Koenigsberg, Max ^a   Brunett, Patrick H ^b   Bynoe, Raymond P ^c   Morris, John A ^d   Tinkoff, Glen ^e   Dalsey, William C ^f   Ochsner, M Gage ^g  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Palmetto Richland Memorial Hospital   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e Christiana Medical Centre   (United States)

^f ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

^g MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

A Severity Characterization of Trauma (ASCOT); Diaspirin cross linked hemoglobin; Hemorrhagic shock; Mortality; Pennsylvania Trauma Outcome Study (PTOS); Trauma; TRISS

Indexed keywords

DIASPIRIN CROSSLINKED HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLUID THERAPY; GLASGOW COMA SCALE; HEMORRHAGIC SHOCK; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SHOCK, HEMORRHAGIC; SHOCK, TRAUMATIC; SURVIVAL ANALYSIS; TRAUMA SEVERITY INDICES;

EID: 0036092276     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-200205000-00011     Document Type: Article

References (36)

1. Gould SA, Moore EE, Hoyt DB, et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg. 1998; 187; 113-120.
2. Nho K, Glower D, Bredehoeft S, Shankar H, Shorr R, Abuchowski A. PEG-bovine hemoglobin; safety in a canine dehydrated hypovolemic- hemorrhagic shock model. Biomater Artif Cells Immobilization Biotechnol. 1992; 20; 511-524.
3. Nelson D, Azari M, Brown R, et al. Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies. Biomater Artif Cells Immobilization Biotechnol. 1992; 20; 423-427.
4. Cohn SM, Farrell TJ. Diaspirin cross-linked hemoglobin resuscitation of hemorrhage; comparison of a blood substitute with hypertonic saline and isotonic saline. J Trauma. 1995; 39; 210-216.
5. DeAngeles DA, Scott AM, Mc Grath AM, et al. Resuscitation from hemorrhagic shock with diaspirin cross-linked hemoglobin, blood, or hetastarch. J Trauma. 1997; 42; 406-412.
6. Frankel HL, Nguyen HB, Shea-Donohue T, Aiton LA, Ratigan J, Malcolm DS. Diaspirin cross-linked hemoglobin is efficacious in gut resuscitation as measured by a GI tract optode. J Trauma. 1996; 40; 231-241.
7. Gulati A, Sen AP. Dose-dependent effect of diaspirin cross-linked hemoglobin on regional blood circulation of severely hemorrhaged rats. Shock. 1998; 9; 65-73.
8. Schultz SC, Hamilton INJ, Malcolm DS. Use of base deficit to compare resuscitation with lactated Ringer’s solution, Haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats. J Trauma. 1993; 35; 619-625.
9. Schultz SC, Powell CC, Burris DG, Nguyen H, Jaffin J, Malcolm DS. The efficacy of diaspirin crosslinked hemoglobin solution resuscitation in a model of uncontrolled hemorrhage. J Trauma. 1994; 37; 408-412.
10. Sloan EP, Koenigsberg M, Bickell WH. The use of diaspirin crossed-linked hemoglobin (DCLHb) solution in the treatment of hemorrhagic hypovolemic shock. Acad Emerg Med. 1995; 2; 364-365.
11. Sloan EP, Koenigsberg M, Gens D, et al. A randomized, controlled efficacy trial of diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock. JAMA. 1999; 282; 1857-1864.
12. Boyd CR, Tolson MA, Copes WS. Evaluating trauma care; the TRISS method-Trauma Score and the Injury Severity Score. J Trauma. 1987; 27; 370-378.
13. Sacco WJ, Copes WS, Bain LWJ, et al. Effect of preinjury illness on trauma patient survival outcome. J Trauma. 1993; 35; 538-542.
14. Champion HR, Copes WS, Sacco WJ, et al. Improved predictions from a severity characterization of trauma (ASCOT) over Trauma and Injury Severity Score (TRISS); results of an independent evaluation. J Trauma. 1996; 40; 42-48.
15. Konvolinka CW, Copes WS, Sacco WJ. Institution and per-surgeon volume versus survival outcome in Pennsylvania’s trauma centers. Am J Surg. 1995; 170; 333-340.
16. Copes WS, Staz CF, Konvolinka CW, Sacco WJ. American College of Surgeons audit filters; associations with patient outcome and resource utilization. J Trauma. 1995; 38; 432-438.
17. Champion HR, Copes WS, Sacco WJ, et al. A new characterization of injury severity. J Trauma. 1990; 30; 539-545.
18. Lewis RJ, Berry DA, Cryer H, et al. Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent; the diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial. Ann Emerg Med. 2001; 38; 397-404.
19. Department of Health and Human Services/Food, and Drug Administration. Protection of human subjects; informed consent and waiver of informed consent requirements in certain emergency research. Final rules (21 CFR part 50.24 and 45 CFR part 46.408). Fed Register. 1996; 61; 51528-51533.
20. U.S. Code of Federal Regulations. 21 (Food and Drugs), parts 50, 56, and 312, 1-88. 1996.
21. Sloan EP, Koenigsberg M, Houghton J, et al. The informed consent process and the use of the exception to informed consent in the clinical trial of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock. Acad Emerg Med. 1999; 1203-1209.
22. Moore EE, Dunn EL, Moore JB, Thompson JS. Penetrating abdominal trauma index. J Trauma. 1981; 21; 439-445.
23. Heckbert SR, Vedder NB, Hoffman W, et al. Outcome after hemorrhagic shock in trauma patients. J Trauma. 1998; 45; 545-549.
24. Sugrue M, Seger M, Sloane D, Compton J, Hillman K, Deane S. Trauma outcomes; a death analysis study. Ir J Med Sci. 1996; 165; 99-104.
25. Champion HR, Copes WS, Sacco WJ, et al. The Major Trauma Outcome Study; establishing national norms for trauma care. J Trauma. 1990; 30; 1356-1365.
26. Lamy M. Clinical benefits of DCLHb following cardiac surgery. Paper presented at; European Society of Intensive Care Medicine (ESICM), Paris, France, September 7-10, 1997 [abstract].
27. Przybelski RJ, Malcolm DS, Burris DG, Winslow RM. Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med. 1991; 117; 143-151.
28. Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colburn WA. Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med. 1996; 24; 1993-2000.
29. Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med. 1997; 25; 1480-1488.
30. Swan SK, Halstenson CE, Collins AJ, Colburn WA, Blue J, Przybelski RJ. Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. Am J Kidney Dis. 1995; 2; 918-923.
31. Gillott AR, Thomas JM, Forrester CF. Development of a statewide trauma registry. J Trauma. 1989; 29; 1667-1672.
32. Demetriades D, Rabinowitz B, Sofianos C. Emergency room thoracotomy for stab wounds to the chest and neck. J Trauma. 1987; 27; 483-485.
33. Shimazu S, Shatney CH. Outcomes of trauma patients with no vital signs on hospital admission. J Trauma. 1983; 23; 213-216.
34. Vij D, Simoni E, Smith RF, et al. Resuscitative thoracotomy for patients with traumatic injury. Surgery. 1983; 94; 554-561.
35. Riou B, Landais P, Vivien B, Stell P, Labbene I, Carli P. Distribution of the probability of survival is a strategic issue for randomized trials in critically ill patients. Anesthesiology. 2001; 95; 56-63.
36. Sloan EP, Koenigsberg MD. The use of ISS and TRISS as measures of injury severity and as mortality predictors in the diaspirin cross-linked hemoglobin (DCLHb) traumatic hemorrhagic shock trial [abstract]. Ann Emerg Med. 2001; 35; S68.